Clinical Benefit with Docetaxel plus Fluorouracil and Cisplatin Compared with Cisplatin and Fluorouracil in a Phase Iii Trial of Advanced Gastric or Gastroesophageal Cancer Adenocarcinoma: The V-325 Study Group
AuthID
P-004-8G2
P-004-8G2